logo

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

Michael A Staszak

USPTO Granted Patents = 9

Average Co-Inventor Count = 5.7

ph-index = 5

Forward Citations = 105(Granted Patents)


Company Filing History:

goldMedal9 out of 4,446 
 
Eli Lilly and Company
 patents

Years Active: 1992-2003

Loading Chart...
9 patents (USPTO):Explore Patents
1. 6538136 - Preparation of substituted piperidin-4-ones (2003-03-25),
2. 6429317 - Indane derivatives for antipsychotic compositions (2002-08-06),
3. 6395735 - Pharmaceutical compounds (2002-05-28),
4. 6211364 - Process for preparing indane-like compounds (2001-04-03),
5. 5977062 - Glycopeptide antibiotic derivatives (1999-11-02),
6. 5843889 - Glycopeptide antibiotic derivatives (1998-12-01),
7. 5840684 - Glycopeptide antibiotic derivatives (1998-11-24),
8. 5530009 - Bis-piperidinyl non-peptidyl neurokinin receptor antagonists (1996-06-25),
9. 5142038 - Process of enantiomeric separation of carbacephem intermediates (1992-08-25),

Title: Innovations by Michael A. Staszak in Pharmaceutical Development

Introduction

Michael A. Staszak is a prominent inventor based in Indianapolis, IN, known for his significant contributions to the fields of pharmaceutical development and chemical innovations. With an impressive portfolio of nine patents, Staszak has made noteworthy advancements that aid in the treatment of various medical conditions.

Latest Patents

Two of his latest patents showcase his inventive capabilities. The first, titled "Preparation of Substituted Piperidin-4-ones," provides a novel process for synthesizing substituted piperidine-4-ones, which are valuable intermediates in pharmaceutical preparations. The second patent, "Indane Derivatives for Antipsychotic Compositions," introduces novel indane-like compounds that serve as potential treatments for psychosis and conditions linked to muscarinic receptor modulation. This patent highlights formulations and methods for utilizing these innovative compounds.

Career Highlights

Staszak is currently associated with Eli Lilly and Company, a leading pharmaceutical company known for its commitment to innovation. Throughout his career, he has been dedicated to developing new therapeutic approaches that can significantly impact patient care and treatment outcomes. His work demonstrates both creativity and practical application in addressing complex health challenges.

Collaborations

Michael has collaborated with several notable colleagues, including Bret E. Huff and Robin D. Cooper. These partnerships emphasize the importance of teamwork and cross-disciplinary efforts in the pursuit of groundbreaking innovations in pharmaceuticals.

Conclusion

In conclusion, Michael A. Staszak's work exemplifies the role of inventors in advancing medical science. His patents reflect a commitment to creating effective treatments for challenging conditions, contributing to the broader landscape of pharmaceutical innovation. As an active member of Eli Lilly and Company, Staszak continues to shape the future of healthcare through his innovative spirit and dedication to improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…